You are here

“Biopsy Without a Knife”

A New Cancer-Imaging Technique

Imaging techniques that rely on contrast dyes are often used to identify tumors or to determine if they’re malignant. Researchers from Tufts University and Lahey Hospital in Massachusetts have now developed a high-powered imaging technique that doesn’t use dyes, but light. The technique was reported in the journal Biomedical Optics Express.

The imaging system uses a multiphoton microscope with automated image processing algorithms to identify cellular and tissue features at the microscopic level, essentially acting like a “biopsy without a knife,” according to Dimitra Pouli, lead author.

Multiphoton microscopy delivers laser light to tissue in very short pulses, which keeps the average power down and doesn’t cause tissue damage. Different components of the tissue interact with the laser light, emitting signals that are picked up by the microscope to create an image with details not usually visible with standard imaging tools.

The system evaluates both cellular and extracellular tissue at the microscopic levels, which allows the identification of cancer metastasis at an earlier stage. The algorithms help to classify the tissues.

The researchers examined fresh biopsies from the peritoneal cavity, the first time healthy and metastatic peritoneal tissue had been successfully studied by combining this microscopy technique with image texture analysis. Eventually they hope to apply the imaging technique directly to areas of the body where cancer is suspected without the need for biopsies or dyes, said Thomas Schnelldorfer, co-leader of the research. “This could ultimately help surgeons identify suspicious or diseased areas directly in the operating room in real time.”

Source: BioSpace, August 7, 2019

Recent Headlines

Scenesse is new treatment for people with rare, painful light sensitivity disease
Humira, Rituxan top list of drugs that added $5.1 billion to nation's health care bill
Lower court rulings cleared the way for generic versions of the MS drug
Maryland man wins lawsuit that alleges that the company's antipsychotic caused his gynecomastia
Antidepressants, ADHD meds are also used to self-poison
Study lists steps that could save close to $300 billion a year
While many victims used THC, the cause remains elusive
Descovy joins Truvada, another Gilead product, in the HIV prophylaxis market
Data show PTC Therapeutics drug preserves lung function